These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6779820)

  • 21. Effect of platelet-generated thromboxane on contractions of the pregnant rat uterus.
    Dubin NH; Blake DA; Egner PG; Ghodgaonkar RB
    Biol Reprod; 1982 Mar; 26(2):289-95. PubMed ID: 7039705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergized activation of human platelets by epinephrine and platelet-activating factor-acether is adenosine diphosphate and thromboxane A2-independent.
    Vargaftig BB; Fouque F; Joseph D; Odiot J; Benveniste J
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():429-33. PubMed ID: 6221558
    [No Abstract]   [Full Text] [Related]  

  • 23. Constitutional thrombocytopathy with subnormal response to thromboxane A2.
    Samama M; Lecrubier C; Conard J; Hotchen M; Breton-Gorius J; Vargaftig B; Chignard M; Lagarde M; Dechavanne M
    Br J Haematol; 1981 Jun; 48(2):293-303. PubMed ID: 7195274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet desensitization by arachidonic acid is associated with the suppression of endoperoxide/thromboxane A2 binding to the membrane receptor.
    Sato T; Hashizume T; Nakao K; Akiba S; Fujii T
    Biochim Biophys Acta; 1989 Aug; 992(2):168-73. PubMed ID: 2503041
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A study of three vasodilating agents as selective inhibitors of thromboxane A2 biosynthesis.
    Greenwald JE; Wong LK; Rao M; Bianchine JR; Panganamala RV
    Biochem Biophys Res Commun; 1978 Oct; 84(4):1112-8. PubMed ID: 728149
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of trapidil on thromboxane A2-induced aggregation of platelets, ischemic changes in heart and biosynthesis of thromboxane A2.
    Ohnishi H; Kosuzume H; Hayashi Y; Yamaguchi K; Suzuki Y; Itoh R
    Prostaglandins Med; 1981 Mar; 6(3):269-81. PubMed ID: 6894333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet aggregability, thromboxane A2 and malonaldehyde formation following administration of aspirin to man.
    Szczeklik A; Gryglewski RJ; Grodzińska L; Musiał J; Serwońska M; Marcinkiewicz E
    Thromb Res; 1979; 15(3-4):405-13. PubMed ID: 494154
    [No Abstract]   [Full Text] [Related]  

  • 28. Elevation of cytoplasmic free calcium concentration by stable thromboxane A2 analogue in human platelets.
    Kawahara Y; Yamanishi J; Furuta Y; Kaibuchi K; Takai Y; Fukuzaki H
    Biochem Biophys Res Commun; 1983 Dec; 117(3):663-9. PubMed ID: 6230078
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The pH dependent platelet utilization of arachidonic acid and a thromboxane A2 mimetic, in vitro.
    Kerry PJ; Paton CJ
    Pharmacol Res Commun; 1985 Jul; 17(7):609-18. PubMed ID: 3931104
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Further studies on the effects of epimers of thromboxane A2 antagonists on platelets and veins.
    Mais DE; Dunlap C; Hamanaka N; Halushka PV
    Eur J Pharmacol; 1985 Apr; 111(1):125-8. PubMed ID: 4018122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biochemical and pharmacological evaluation of thromboxane synthetase inhibitors.
    Gorman RR
    Adv Prostaglandin Thromboxane Res; 1980; 6():417-25. PubMed ID: 6247892
    [No Abstract]   [Full Text] [Related]  

  • 32. Binding of a radioiodinated 13-azapinane thromboxane antagonist to platelets: correlation with antiaggregatory activity in different species.
    Narumiya S; Okuma M; Ushikubi F
    Br J Pharmacol; 1986 Jun; 88(2):323-31. PubMed ID: 3730697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Why do some beta adrenergic agonists inhibit generation of thromboxane A2 in incubates of platelets with arachidonic acid?
    Chignard M; Vargaftig BB
    Biochem Pharmacol; 1978; 27(11):1603-6. PubMed ID: 29642
    [No Abstract]   [Full Text] [Related]  

  • 34. Bioassay of thromboxane A2 by contraction of guinea-pig lung parenchymal strip.
    Spławiński J; Wojtaszek B; Marcinkiewicz E
    Thromb Res; 1981 Jan 1-15; 21(1-2):35-44. PubMed ID: 6112804
    [No Abstract]   [Full Text] [Related]  

  • 35. Arachidonic acid-induced platelet aggregation independent of ADP-release in a patient with a bleeding disorder due to platelet storage pool disease.
    Minkes MS; Joist JH; Needleman P
    Thromb Res; 1979; 15(1-2):169-79. PubMed ID: 384595
    [No Abstract]   [Full Text] [Related]  

  • 36. Dissociation of vasoconstrictor and platelet aggregatory activities of thromboxane by carbocyclic thromboxane A2, a stable analog of thromboxane A2.
    Lefer AM; Smith EF; Araki H; Smith JB; Aharony D; Claremon DA; Magolda RL; Nicolaou KC
    Proc Natl Acad Sci U S A; 1980 Mar; 77(3):1706-10. PubMed ID: 6929517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carbocromen inhibits arachidonic acid-induced platelet aggregation and TXA2 formation.
    Heinroth I; Förster W
    Prostaglandins Leukot Med; 1984 Apr; 14(1):13-4. PubMed ID: 6427789
    [No Abstract]   [Full Text] [Related]  

  • 38. Megakaryocyte thromboxane production induced by platelet stimuli during in vitro culture.
    Walenga RW; Miller JL; Stuart MJ
    Exp Hematol; 1985 Feb; 13(2):87-91. PubMed ID: 3918879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Salicylic acid fails to inhibit generation of thromboxane A2 activity in platelets after in vivo administration to the rat.
    Vargaftig BB
    J Pharm Pharmacol; 1978 Feb; 30(2):101-4. PubMed ID: 24092
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of propranolol and 4-hydroxypropranolol on platelet aggregation and thromboxane A2 generation.
    Mehta J; Mehta P; Ostrowski N
    Clin Pharmacol Ther; 1983 Nov; 34(5):559-64. PubMed ID: 6627818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.